These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9106980)

  • 1. Effect of ursodeoxycholic acid on the inflammatory activity of indomethacin-induced intestinal inflammation in rats.
    Kullmann F; Gross V; Rüschoff J; Arndt H; Benda W; Winkler von Mohrenfels A; Schölmerich J
    Z Gastroenterol; 1997 Mar; 35(3):171-8. PubMed ID: 9106980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effect of ursodeoxycholic acid on mucosal damage in trinitrobenzene sulphonic acid-induced colitis.
    Kullmann F; Arndt H; Gross V; Rüschoff J; Schölmerich J
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1205-11. PubMed ID: 9471027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis.
    Kuroda M; Yoshida N; Ichikawa H; Takagi T; Okuda T; Naito Y; Okanoue T; Yoshikawa T
    Int J Mol Med; 2006 Jan; 17(1):89-93. PubMed ID: 16328016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taurochenodeoxycholic acid ameliorates and ursodeoxycholic acid exacerbates small intestinal inflammation.
    Uchida A; Yamada T; Hayakawa T; Hoshino M
    Am J Physiol; 1997 May; 272(5 Pt 1):G1249-57. PubMed ID: 9176237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid ameliorates experimental ileitis counteracting intestinal barrier dysfunction and oxidative stress.
    Bernardes-Silva CF; Damião AO; Sipahi AM; Laurindo FR; Iriya K; Lopasso FP; Buchpiguel CA; Lordello ML; Agostinho CL; Laudanna AA
    Dig Dis Sci; 2004 Oct; 49(10):1569-74. PubMed ID: 15573906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study of the impact of a single use of indometacine on the morphological structure of the mucous coat of the stomach and small intestine].
    Vymiatina ZK; Ivanova LA; Krylova SG
    Eksp Klin Gastroenterol; 2006; (3):32-6, 70. PubMed ID: 17203840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of bile in pathogenesis of indomethacin-induced enteropathy.
    Jacob M; Foster R; Sigthorsson G; Simpson R; Bjarnason I
    Arch Toxicol; 2007 Apr; 81(4):291-8. PubMed ID: 17151867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral glutamine attenuates indomethacin-induced small intestinal damage.
    Basivireddy J; Jacob M; Balasubramanian KA
    Clin Sci (Lond); 2004 Sep; 107(3):281-9. PubMed ID: 15128285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of ursodeoxycholic acid on N-methylnitrosourea-induced colon carcinogenesis and colonic mucosal telomerase activity in F344 rats.
    Narisawa T; Fukaura Y; Terada K; Sekiguchi H
    J Exp Clin Cancer Res; 1999 Jun; 18(2):259-66. PubMed ID: 10464717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of bile acids on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced aberrant crypt foci and DNA adduct formation in the rat colon.
    Ueyama Y; Monden Y; He XB; Lin CX; Momen MA; Mimura S; Umemoto A
    J Exp Clin Cancer Res; 2002 Dec; 21(4):577-83. PubMed ID: 12636105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual action of nitric oxide in pathogenesis of indomethacin-induced small intestinal ulceration in rats.
    Tanaka A; Kunikata T; Mizoguchi H; Kato S; Takeuchi K
    J Physiol Pharmacol; 1999 Sep; 50(3):405-17. PubMed ID: 10574470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress.
    Serviddio G; Pereda J; Pallardó FV; Carretero J; Borras C; Cutrin J; Vendemiale G; Poli G; Viña J; Sastre J
    Hepatology; 2004 Mar; 39(3):711-20. PubMed ID: 14999689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
    Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal motor disorders associated with cyclical bacterial overgrowth in a rat model of enteritis.
    Porras M; Martín MT; Soler M; Vergara P
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G58-64. PubMed ID: 14962848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid.
    Hess LM; Krutzsch MF; Guillen J; Chow HH; Einspahr J; Batta AK; Salen G; Reid ME; Earnest DL; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):861-7. PubMed ID: 15159320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indomethacin-induced disturbances in villous microcirculation in the rat ileum.
    Ruh J; Schmidt E; Vogel F; Klar E
    Microvasc Res; 1999 Sep; 58(2):137-43. PubMed ID: 10458929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal effects of nonselective and selective cyclooxygenase inhibitors in the rat.
    Menozzi A; Pozzoli C; Giovannini E; Solenghi E; Grandi D; Bonardi S; Bertini S; Vasina V; Coruzzi G
    Eur J Pharmacol; 2006 Dec; 552(1-3):143-50. PubMed ID: 17069793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc protects against indomethacin-induced damage in the rat small intestine.
    Sivalingam N; Pichandi S; Chapla A; Dinakaran A; Jacob M
    Eur J Pharmacol; 2011 Mar; 654(1):106-16. PubMed ID: 21185825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of chymase-dependent matrix metalloproteinase-9 activation on indomethacin-induced small intestinal damages in rats.
    Kakimoto K; Takai S; Murano M; Ishida K; Yoda Y; Inoue T; Jin D; Umegaki E; Higuchi K
    J Pharmacol Exp Ther; 2010 Feb; 332(2):684-9. PubMed ID: 19996300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.